Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
59
COGT Quote, Financials, Valuation and Earnings
Last price:
$39.75
Seasonality move
:
-9.39%
Day range:
$39.60 - $40.40
52-week range:
$3.72 - $43.73
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
55.99x
P/B ratio:
31.35x
Volume:
581K
Avg. volume:
3.2M
1-year change:
405.47%
Market cap:
$6.1B
Revenue:
--
EPS (TTM):
-$2.37
Cogent Biosciences, Inc. SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
COGT
Cogent Biosciences, Inc.
|
08/10/2020 | 10-Q | 10-Q filing on 08/10/2020 | View Form |
|
COGT
Cogent Biosciences, Inc.
|
05/11/2020 | 10-Q | 10-Q filing on 05/11/2020 | View Form |
|
COGT
Cogent Biosciences, Inc.
|
03/13/2020 | 10-K | 10-K filing on 03/13/2020 | View Form |
|
COGT
Cogent Biosciences, Inc.
|
11/12/2019 | 10-Q | 10-Q filing on 11/12/2019 | View Form |
|
COGT
Cogent Biosciences, Inc.
|
08/09/2019 | 10-Q | 10-Q filing on 08/09/2019 | View Form |
|
COGT
Cogent Biosciences, Inc.
|
05/10/2019 | 10-Q | 10-Q filing on 05/10/2019 | View Form |
|
COGT
Cogent Biosciences, Inc.
|
03/18/2019 | 10-K | 10-K filing on 03/18/2019 | View Form |
|
COGT
Cogent Biosciences, Inc.
|
11/08/2018 | 10-Q | 10-Q filing on 11/08/2018 | View Form |
|
COGT
Cogent Biosciences, Inc.
|
08/08/2018 | 10-Q | 10-Q filing on 08/08/2018 | View Form |
|
COGT
Cogent Biosciences, Inc.
|
05/09/2018 | 10-Q | 10-Q filing on 05/09/2018 | View Form |
|
COGT
Cogent Biosciences, Inc.
|
03/14/2018 | 10-K | 10-K filing on 03/14/2018 | View Form |
|
COGT
Cogent Biosciences, Inc.
|
11/08/2017 | 10-Q | 10-Q filing on 11/08/2017 | View Form |
|
COGT
Cogent Biosciences, Inc.
|
08/09/2017 | 10-Q | 10-Q filing on 08/09/2017 | View Form |
|
COGT
Cogent Biosciences, Inc.
|
05/09/2017 | 10-Q | 10-Q filing on 05/09/2017 | View Form |
|
COGT
Cogent Biosciences, Inc.
|
03/14/2017 | 10-K | 10-K filing on 03/14/2017 | View Form |
|
COGT
Cogent Biosciences, Inc.
|
11/03/2016 | 10-Q | 10-Q filing on 11/03/2016 | View Form |
|
COGT
Cogent Biosciences, Inc.
|
08/08/2016 | 10-Q | 10-Q filing on 08/08/2016 | View Form |
|
COGT
Cogent Biosciences, Inc.
|
05/05/2016 | 10-Q | 10-Q filing on 05/05/2016 | View Form |
|
COGT
Cogent Biosciences, Inc.
|
03/18/2016 | 10-K | 10-K filing on 03/18/2016 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
